Columbus Macro’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3M Buy
28,562
+680
+2% +$216K 0.81% 46
2026
Q1
$9.62M Buy
27,882
+910
+3% +$318K 1.03% 30
2025
Q4
$7.92M Buy
26,972
+390
+1% +$113K 0.87% 46
2025
Q3
$8.12M Buy
26,582
+1,332
+5% +$364K 0.92% 38
2025
Q2
$6.33M Buy
25,250
+1,952
+8% +$448K 0.78% 52
2025
Q1
$4.88M Buy
23,298
+5,689
+32% +$1.19M 0.64% 68
2024
Q4
$3.7M Buy
17,609
+14,645
+494% +$3.51M 0.51% 80
2024
Q3
$713K Buy
2,964
+158
+6% +$36.5K 0.26% 118
2024
Q2
$631K Sell
2,806
-35
-1% -$7.56K 0.24% 122
2024
Q1
$605K Sell
2,841
-157
-5% -$33K 0.23% 129
2023
Q4
$629K Buy
2,998
+18
+0.6% +$3.38K 0.25% 125
2023
Q3
$519K Sell
2,980
-68
-2% -$12.5K 0.22% 125
2023
Q2
$597K Buy
3,048
+1,085
+55% +$208K 0.24% 114
2023
Q1
$386K Buy
1,963
+110
+6% +$22.5K 0.14% 140
2022
Q4
$385K Buy
1,853
+120
+7% +$27.1K 0.15% 141
2022
Q3
$360K Sell
1,733
-13
-0.7% -$3K 0.15% 138
2022
Q2
$422K Buy
+1,746
New +$421K 0.16% 126

Other funds holding LHX

Columbus Macro's LHX Position: Q2 2026 in Review

Columbus Macro increased its L3Harris (LHX) stake by 2.4% in Q2 2026, buying an estimated $216K and bringing the position to 28,562 shares worth $8.3M. The position accounts for 0.81% of the portfolio, ranked #46.

Columbus Macro first reported a position in LHX in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.62M in Q1 2026. 1,691 funds tracked by Wall St. Rank hold LHX as of Q2 2026.

  • Columbus Macro held 28,562 shares of L3Harris worth $8.3M as of Q2 2026.
  • Columbus Macro bought 680 L3Harris shares in Q2 2026, an estimated $216K.
  • L3Harris made up 0.81% of Columbus Macro's portfolio in Q2 2026, its #46 holding.
  • Columbus Macro first reported a position in L3Harris in Q2 2022 and has held it in 17 quarters since.
  • Columbus Macro's L3Harris position peaked at $9.62M in Q1 2026.
  • 1,691 funds tracked by Wall St. Rank held L3Harris as of Q2 2026.

Based on Columbus Macro's 13F filing for Q2 2026, filed 22 Jul 2026.